Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Role of growth factors in improved skin flap viability caused by phosphodiesterase-5 inhibitor.

Bandera BC, Pham T, Hill-Pryor C, Bah-Sow M, Franco N, Prasad BM, Pizarro J.

Am Surg. 2010 Jun;76(6):614-7.

PMID:
20583517
2.

Short- and long-term effects of sildenafil on skin flap survival in rats.

Hart K, Baur D, Hodam J, Lesoon-Wood L, Parham M, Keith K, Vazquez R, Ager E, Pizarro J.

Laryngoscope. 2006 Apr;116(4):522-8.

PMID:
16585853
3.

Evaluation of the effect of sildenafil and vascular endothelium growth factor combination treatment on skin flap survival in rats.

Tsai JW, Ayubi FS, Hart KL, Baur DA, Parham MA, Moon JK, Vazquez R, Chasen AB, Zhang Z, Pizarro JM.

Aesthetic Plast Surg. 2008 Jul;32(4):624-31. doi: 10.1007/s00266-008-9166-2. Epub 2008 Apr 29.

PMID:
18443849
4.

The influence of sildenafil on random skin flap survival in rats: an experimental study.

Sarifakioglu N, Gokrem S, Ates L, Akbuga UB, Aslan G.

Br J Plast Surg. 2004 Dec;57(8):769-72.

PMID:
15544775
5.

Effect of transfection time on the survival of epigastric skin flaps pretreated with adenovirus encoding the VEGF gene.

Gurunluoglu R, Ozer K, Skugor B, Lubiatowski P, Carnevale K, Siemionow M.

Ann Plast Surg. 2002 Aug;49(2):161-9.

PMID:
12187344
6.

Efficacy and mechanism of adenovirus-mediated VEGF-165 gene therapy for augmentation of skin flap viability.

Huang N, Khan A, Ashrafpour H, Neligan PC, Forrest CR, Kontos CD, Pang CY.

Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H127-37. Epub 2006 Feb 3.

7.

Improved flap viability with site-specific delivery of sildenafil citrate using fibrin glue.

Ulusoy MG, Uysal A, Koçer U, Karaaslan O, Cuzdan SS, Ayyildiz A, Ustün H.

Ann Plast Surg. 2005 Sep;55(3):292-6.

PMID:
16106170
8.

Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism.

Khan A, Ashrafpour H, Huang N, Neligan PC, Kontos C, Zhong A, Forrest CR, Pang CY.

Am J Physiol Regul Integr Comp Physiol. 2004 Nov;287(5):R1219-29. Epub 2004 Jun 24.

9.

Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model.

Zhang F, Fischer K, Komorowska-Timek E, Guo M, Cui D, Dorsett-Martin W, Buncke HJ, Lineaweaver WC.

Ann Plast Surg. 2001 Mar;46(3):314-9.

PMID:
11293526
10.

Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.

Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS.

Gene Ther. 2001 Apr;8(7):523-33.

11.

Improvement of venous flap survival by application of vascular endothelial growth factor in a rat model.

Zhang F, Brooks D, Chen W, Mustain W, Chen MB, Lineaweaver WC.

Ann Plast Surg. 2006 Jun;56(6):670-3.

PMID:
16721083
12.

PDE-5 inhibition improves skin flap viability in rats that are exposed to nicotine.

Shah A, Pfaff MJ, Assi R, Wu W, Steinbacher DM.

Microsurgery. 2014 Jul;34(5):390-7. doi: 10.1002/micr.22237. Epub 2014 Mar 7.

PMID:
24610727
13.

Enhancement of flap survival and changes in angiogenic gene expression after AAV2-mediated VEGF gene transfer to rat ischemic flaps.

Wang XT, Avanessian B, Ma Q, Durfee H, Tang YQ, Liu PY.

Wound Repair Regen. 2011 Jul-Aug;19(4):498-504. doi: 10.1111/j.1524-475X.2011.00705.x. Epub 2011 Jun 7.

PMID:
21649787
14.

The effect of single administration of vascular endothelial growth factor or L-arginine on necrosis and vasculature of the epigastric flap in the rat model.

Komorowska-Timek E, Timek TA, Brevetti LS, Zhang F, Lineaweaver WC, Buncke HJ.

Br J Plast Surg. 2004 Jun;57(4):317-25.

PMID:
15145734
15.

The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration.

Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ.

Br J Plast Surg. 2000 Apr;53(3):234-9.

PMID:
10738331
16.

Recombinant leptin administration improves early angiogenesis in full-thickness skin flaps: an experimental study.

Liapakis IE, Anagnostoulis S, Karayiannakis AJ, Korkolis DP, Lambropoulou M, Arnaud E, Simopoulos CE.

In Vivo. 2008 Mar-Apr;22(2):247-52. Erratum in: In Vivo. 2008 May-Jun;22(3):401. Karayiannakis, A [corrected to Karayiannakis, A J]. In Vivo. 2008 Nov-Dec;22(6):886.

17.

Vascular endothelial growth factor (VEGF) expression and the effect of exogenous VEGF on survival of a random flap in the rat.

Zhang F, Oswald T, Lin S, Cai Z, Lei M, Jones M, Angel MF, Lineaweaver WC.

Br J Plast Surg. 2003 Oct;56(7):653-9.

PMID:
12969663
18.

[Angiogenesis VEGF165 gene therapy with AdVEGF- a new delay procedure for flaps].

Holzbach T, Taskov C, Neshkova I, Holm PS, Konerding MA, Schams D, Gänsbacher B, Biemer E, Giunta RE.

Handchir Mikrochir Plast Chir. 2005 Dec;37(6):365-74. German.

PMID:
16388451
19.

[The effects of vascular endothelial growth factor on survival of reverse flow axial skin flaps].

Sun Q, Zheng Y, Ma T.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Jan;21(1):44-7. Chinese.

PMID:
17305004
20.

Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats.

Meirer R, Huemer GM, Oehlbauer M, Wanner S, Piza-Katzer H, Kamelger FS.

J Plast Reconstr Aesthet Surg. 2007;60(3):266-71. Epub 2006 Jun 12.

PMID:
17293284

Supplemental Content

Support Center